Potential anti-diabetic isoprenoids and a long-chain δ-lactone from frangipani (Plumeria rubra)

Sheng-Nan Zhang,Hong-Zhi Song,Rui-Jing Ma,Cheng-Qin Liang,Heng-Shan Wang,Qin-Gang Tan
DOI: https://doi.org/10.1016/j.fitote.2020.104684
IF: 3.204
2020-10-01
Fitoterapia
Abstract:<p>A decoction of <em>Plumeria rubra</em> flowers has been used traditionally for the treatment of diabetes in China and Mexico. Chemical investigations on the bioactive constituents of these flowers led to the isolation of 30 compounds, including the four new compounds, one iridoiod (<strong>1</strong>), two triterpenoids (<strong>4</strong>, <strong>5</strong>), and a long-chain <em>δ</em>-lactone (<strong>16</strong>). In addition, 26 known compounds (<strong>2</strong>, <strong>3</strong>, <strong>6</strong>–<strong>15</strong>, <strong>17</strong>–<strong>30</strong>) are also reported. All of these compounds were identified on the basis of spectroscopic data interpretation and the absolute configurations of compound <strong>4, 5, 16</strong> were determined by Mosher<em>'</em>s method. Compounds <strong>1</strong>–<strong>4</strong>, <strong>7</strong>, <strong>8</strong> and <strong>16</strong> showed moderate to significant inhibitory activities against <em>α</em>-glucosidase and protein tyrosine phosphatase 1B, with <strong>4</strong> having IC<sub>50</sub> values of 19.45 μM and 0.21 μM, respectively.</p>
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?